Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 1/2018

01-01-2018 | Original Article – Clinical Oncology

A novel biopsy-related parameter derived from location and relationship of positive cores on standard 12-core trans-rectal ultrasound-guided prostate biopsy: a useful parameter for predicting tumor volume compared to number of positive cores

Authors: Sangjun Yoo, Hwancheol Son, Sohee Oh, Juhyun Park, Sung Yong Cho, Min Chul Cho, Hyeon Jeong

Published in: Journal of Cancer Research and Clinical Oncology | Issue 1/2018

Login to get access

Abstract

Purpose

To develop a novel biopsy-related parameter, named overlapping line, defined as the line between the adjacent positive cores on 12-core trans-rectal ultrasound-guided prostate biopsy, and evaluated the value of overlapping line for predicting tumor volume in the final pathologic examination.

Methods

Among patients with prostate cancer who underwent radical prostatectomy at Boramae Medical Center, 470 patients who underwent standard 12-core trans-rectal ultrasound-guided prostate biopsy were selected for the analysis. The number of overlapping line was determined in each patient, and its effects on tumor volume were evaluated after adjusting for other variables.

Results

Median prostate specific antigen level was 9.1 ng/mL, and the maximum % cancer in positive cores was 42.8%. Median numbers of positive cores and overlapping lines were three and two, respectively. The pathologic stage was T2 or less, T3a, and T3b or greater in 297 (63.5%), 104 (22.2%), and 67 patients (14.3%), respectively. Median tumor volume in prostatectomy specimen was 3.4 mL. In multivariable analysis, the number of overlapping lines (B 0.750, p < 0.001) was a significant predictor for tumor volume, in addition to prostate specific antigen level and maximum % cancer in positive cores. In addition, the model with overlapping line showed superior accuracy compared to the model with positive core based adjusted r 2 (0.467 vs. 0.456).

Conclusions

The number of overlapping lines, a novel prostate biopsy-related variable, is thought to be a more reliable predictor for tumor volume compared to the number of positive cores and could be easily applied to routine daily practice.
Appendix
Available only for authorised users
Literature
go back to reference Barentsz JO, Weinreb JC, Verma S, Thoeny HC, Tempany CM, Shtern F, Padhani AR, Margolis D, Macura KJ, Haider MA, Cornud F, Choyke PL (2016) Synopsis of the PI-RADS v2 guidelines for multiparametric prostate magnetic resonance imaging and recommendations for use. Eur Urol 69(1):41–49. doi:10.1016/j.eururo.2015.08.038 CrossRefPubMed Barentsz JO, Weinreb JC, Verma S, Thoeny HC, Tempany CM, Shtern F, Padhani AR, Margolis D, Macura KJ, Haider MA, Cornud F, Choyke PL (2016) Synopsis of the PI-RADS v2 guidelines for multiparametric prostate magnetic resonance imaging and recommendations for use. Eur Urol 69(1):41–49. doi:10.​1016/​j.​eururo.​2015.​08.​038 CrossRefPubMed
go back to reference Castiglione F, Dell’Oglio P, Tosco L, Everaerts W, Albersen M, Hakim L, Van den Broeck T, Moris L, Claessens F, Briganti A, Montorsi F, Van Poppel H, Joniau S (2017) Tumor volume and clinical failure in high-risk prostate cancer patients treated with radical prostatectomy. Prostate 77(1):3–9. doi:10.1002/pros.23242 CrossRefPubMed Castiglione F, Dell’Oglio P, Tosco L, Everaerts W, Albersen M, Hakim L, Van den Broeck T, Moris L, Claessens F, Briganti A, Montorsi F, Van Poppel H, Joniau S (2017) Tumor volume and clinical failure in high-risk prostate cancer patients treated with radical prostatectomy. Prostate 77(1):3–9. doi:10.​1002/​pros.​23242 CrossRefPubMed
go back to reference Cornud F, Khoury G, Bouazza N, Beuvon F, Peyromaure M, Flam T, Zerbib M, Legmann P, Delongchamps NB (2014) Tumor target volume for focal therapy of prostate cancer-does multiparametric magnetic resonance imaging allow for a reliable estimation? J Urol 191(5):1272–1279. doi:10.1016/j.juro.2013.12.006 CrossRefPubMed Cornud F, Khoury G, Bouazza N, Beuvon F, Peyromaure M, Flam T, Zerbib M, Legmann P, Delongchamps NB (2014) Tumor target volume for focal therapy of prostate cancer-does multiparametric magnetic resonance imaging allow for a reliable estimation? J Urol 191(5):1272–1279. doi:10.​1016/​j.​juro.​2013.​12.​006 CrossRefPubMed
go back to reference Dall’Era MA, Konety BR, Cowan JE, Shinohara K, Stauf F, Cooperberg MR, Meng MV, Kane CJ, Perez N, Master VA, Carroll PR (2008) Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer 112(12):2664–2670. doi:10.1002/cncr.23502 CrossRefPubMed Dall’Era MA, Konety BR, Cowan JE, Shinohara K, Stauf F, Cooperberg MR, Meng MV, Kane CJ, Perez N, Master VA, Carroll PR (2008) Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer 112(12):2664–2670. doi:10.​1002/​cncr.​23502 CrossRefPubMed
go back to reference Descazeaud A, Rubin MA, Allory Y, Burchardt M, Salomon L, Chopin D, Abbou C, de la Taille A (2005) What information are urologists extracting from prostate needle biopsy reports and what do they need for clinical management of prostate cancer? Eur Urol 48(6):911–915. doi:10.1016/j.eururo.2005.07.011 CrossRefPubMed Descazeaud A, Rubin MA, Allory Y, Burchardt M, Salomon L, Chopin D, Abbou C, de la Taille A (2005) What information are urologists extracting from prostate needle biopsy reports and what do they need for clinical management of prostate cancer? Eur Urol 48(6):911–915. doi:10.​1016/​j.​eururo.​2005.​07.​011 CrossRefPubMed
go back to reference Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA (2016) The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol 40(2):244–252. doi:10.1097/pas.0000000000000530 PubMed Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA (2016) The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol 40(2):244–252. doi:10.​1097/​pas.​0000000000000530​ PubMed
go back to reference Knoedler JJ, Karnes RJ, Thompson RH, Rangel LJ, Bergstralh EJ, Boorjian SA (2014) The association of tumor volume with mortality following radical prostatectomy. Prostate Cancer Prostatic Dis 17(2):144–148. doi:10.1038/pcan.2013.61 CrossRefPubMed Knoedler JJ, Karnes RJ, Thompson RH, Rangel LJ, Bergstralh EJ, Boorjian SA (2014) The association of tumor volume with mortality following radical prostatectomy. Prostate Cancer Prostatic Dis 17(2):144–148. doi:10.​1038/​pcan.​2013.​61 CrossRefPubMed
go back to reference Meyer CP, Hansen J, Boehm K, Tilki D, Abdollah F, Trinh QD, Fisch M, Sauter G, Graefen M, Huland H, Chun FK, Ahyai SA (2017) Tumor volume improves the long-term prediction of biochemical recurrence-free survival after radical prostatectomy for localized prostate cancer with positive surgical margins. World J Urol 35(2):199–206. doi:10.1007/s00345-016-1861-z CrossRefPubMed Meyer CP, Hansen J, Boehm K, Tilki D, Abdollah F, Trinh QD, Fisch M, Sauter G, Graefen M, Huland H, Chun FK, Ahyai SA (2017) Tumor volume improves the long-term prediction of biochemical recurrence-free survival after radical prostatectomy for localized prostate cancer with positive surgical margins. World J Urol 35(2):199–206. doi:10.​1007/​s00345-016-1861-z CrossRefPubMed
go back to reference Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M, Fossati N, Gross T, Henry AM, Joniau S, Lam TB, Mason MD, Matveev VB, Moldovan PC, van den Bergh RCN, van den Broeck T, van den Poel HG, van den Kwast TH, Rouvière O, Schoots IG, Wiegel T, Cornford P (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 71(4):618–629. doi:10.1016/j.eururo.2016.08.003 CrossRefPubMed Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M, Fossati N, Gross T, Henry AM, Joniau S, Lam TB, Mason MD, Matveev VB, Moldovan PC, van den Bergh RCN, van den Broeck T, van den Poel HG, van den Kwast TH, Rouvière O, Schoots IG, Wiegel T, Cornford P (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 71(4):618–629. doi:10.​1016/​j.​eururo.​2016.​08.​003 CrossRefPubMed
go back to reference Mouraviev V, Villers A, Bostwick DG, Wheeler TM, Montironi R, Polascik TJ (2011) Understanding the pathological features of focality, grade and tumour volume of early-stage prostate cancer as a foundation for parenchyma-sparing prostate cancer therapies: active surveillance and focal targeted therapy. BJU Int 108(7):1074–1085. doi:10.1111/j.1464-410X.2010.10039.x CrossRefPubMed Mouraviev V, Villers A, Bostwick DG, Wheeler TM, Montironi R, Polascik TJ (2011) Understanding the pathological features of focality, grade and tumour volume of early-stage prostate cancer as a foundation for parenchyma-sparing prostate cancer therapies: active surveillance and focal targeted therapy. BJU Int 108(7):1074–1085. doi:10.​1111/​j.​1464-410X.​2010.​10039.​x CrossRefPubMed
go back to reference Priester A, Natarajan S, Khoshnoodi P, Margolis DJ, Raman SS, Reiter RE, Huang J, Grundfest W, Marks LS (2017) Magnetic resonance imaging underestimation of prostate cancer geometry: use of patient specific molds to correlate images with whole mount pathology. J Urol 197(2):320–326. doi:10.1016/j.juro.2016.07.084 CrossRefPubMed Priester A, Natarajan S, Khoshnoodi P, Margolis DJ, Raman SS, Reiter RE, Huang J, Grundfest W, Marks LS (2017) Magnetic resonance imaging underestimation of prostate cancer geometry: use of patient specific molds to correlate images with whole mount pathology. J Urol 197(2):320–326. doi:10.​1016/​j.​juro.​2016.​07.​084 CrossRefPubMed
go back to reference Rud E, Klotz D, Rennesund K, Baco E, Berge V, Lien D, Svindland A, Lundeby E, Berg RE, Eri LM, Eggesbo HB (2014) Detection of the index tumour and tumour volume in prostate cancer using T2-weighted and diffusion-weighted magnetic resonance imaging (MRI) alone. BJU Int 114(6b):E32–E42. doi:10.1111/bju.12637 CrossRefPubMed Rud E, Klotz D, Rennesund K, Baco E, Berge V, Lien D, Svindland A, Lundeby E, Berg RE, Eri LM, Eggesbo HB (2014) Detection of the index tumour and tumour volume in prostate cancer using T2-weighted and diffusion-weighted magnetic resonance imaging (MRI) alone. BJU Int 114(6b):E32–E42. doi:10.​1111/​bju.​12637 CrossRefPubMed
go back to reference Salami SS, Ben-Levi E, Yaskiv O, Ryniker L, Turkbey B, Kavoussi LR, Villani R, Rastinehad AR (2015) In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy? BJU Int 115(4):562–570. doi:10.1111/bju.12938 CrossRefPubMed Salami SS, Ben-Levi E, Yaskiv O, Ryniker L, Turkbey B, Kavoussi LR, Villani R, Rastinehad AR (2015) In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy? BJU Int 115(4):562–570. doi:10.​1111/​bju.​12938 CrossRefPubMed
go back to reference Stephenson AJ, Scardino PT, Eastham JA, Bianco FJ Jr, Dotan ZA, DiBlasio CJ, Reuther A, Klein EA, Kattan MW (2005) Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol Off J Am Soc Clin Oncol 23(28):7005–7012. doi:10.1200/jco.2005.01.867 CrossRef Stephenson AJ, Scardino PT, Eastham JA, Bianco FJ Jr, Dotan ZA, DiBlasio CJ, Reuther A, Klein EA, Kattan MW (2005) Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol Off J Am Soc Clin Oncol 23(28):7005–7012. doi:10.​1200/​jco.​2005.​01.​867 CrossRef
go back to reference Ting F, van Leeuwen PJ, Delprado W, Haynes AM, Brenner P, Stricker PD (2015) Tumor volume in insignificant prostate cancer: increasing the threshold is a safe approach to reduce over-treatment. Prostate 75(15):1768–1773. doi:10.1002/pros.23062 CrossRefPubMed Ting F, van Leeuwen PJ, Delprado W, Haynes AM, Brenner P, Stricker PD (2015) Tumor volume in insignificant prostate cancer: increasing the threshold is a safe approach to reduce over-treatment. Prostate 75(15):1768–1773. doi:10.​1002/​pros.​23062 CrossRefPubMed
go back to reference van As NJ, Norman AR, Thomas K, Khoo VS, Thompson A, Huddart RA, Horwich A, Dearnaley DP, Parker CC (2008) Predicting the probability of deferred radical treatment for localised prostate cancer managed by active surveillance. Eur Urol 54(6):1297–1305. doi:10.1016/j.eururo.2008.02.039 CrossRefPubMed van As NJ, Norman AR, Thomas K, Khoo VS, Thompson A, Huddart RA, Horwich A, Dearnaley DP, Parker CC (2008) Predicting the probability of deferred radical treatment for localised prostate cancer managed by active surveillance. Eur Urol 54(6):1297–1305. doi:10.​1016/​j.​eururo.​2008.​02.​039 CrossRefPubMed
go back to reference van den Bergh RC, Vasarainen H, van der Poel HG, Vis-Maters JJ, Rietbergen JB, Pickles T, Cornel EB, Valdagni R, Jaspars JJ, van der Hoeven J, Staerman F, Oomens EH, Rannikko A, Roemeling S, Steyerberg EW, Roobol MJ, Schroder FH, Bangma CH (2010) Short-term outcomes of the prospective multicentre ‘Prostate Cancer Research International: Active Surveillance’ study. BJU Int 105(7):956–962. doi:10.1111/j.1464-410X.2009.08887.x CrossRefPubMed van den Bergh RC, Vasarainen H, van der Poel HG, Vis-Maters JJ, Rietbergen JB, Pickles T, Cornel EB, Valdagni R, Jaspars JJ, van der Hoeven J, Staerman F, Oomens EH, Rannikko A, Roemeling S, Steyerberg EW, Roobol MJ, Schroder FH, Bangma CH (2010) Short-term outcomes of the prospective multicentre ‘Prostate Cancer Research International: Active Surveillance’ study. BJU Int 105(7):956–962. doi:10.​1111/​j.​1464-410X.​2009.​08887.​x CrossRefPubMed
Metadata
Title
A novel biopsy-related parameter derived from location and relationship of positive cores on standard 12-core trans-rectal ultrasound-guided prostate biopsy: a useful parameter for predicting tumor volume compared to number of positive cores
Authors
Sangjun Yoo
Hwancheol Son
Sohee Oh
Juhyun Park
Sung Yong Cho
Min Chul Cho
Hyeon Jeong
Publication date
01-01-2018
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 1/2018
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-017-2525-0

Other articles of this Issue 1/2018

Journal of Cancer Research and Clinical Oncology 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.